Cargando…

Rituximab use in late antibody-mediated rejection

Detalles Bibliográficos
Autor principal: Bansal, S. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015506/
https://www.ncbi.nlm.nih.gov/pubmed/27795622
http://dx.doi.org/10.4103/0971-4065.179305
_version_ 1782452449953447936
author Bansal, S. B.
author_facet Bansal, S. B.
author_sort Bansal, S. B.
collection PubMed
description
format Online
Article
Text
id pubmed-5015506
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50155062016-10-28 Rituximab use in late antibody-mediated rejection Bansal, S. B. Indian J Nephrol Commentary Medknow Publications & Media Pvt Ltd 2016-09 /pmc/articles/PMC5015506/ /pubmed/27795622 http://dx.doi.org/10.4103/0971-4065.179305 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Commentary
Bansal, S. B.
Rituximab use in late antibody-mediated rejection
title Rituximab use in late antibody-mediated rejection
title_full Rituximab use in late antibody-mediated rejection
title_fullStr Rituximab use in late antibody-mediated rejection
title_full_unstemmed Rituximab use in late antibody-mediated rejection
title_short Rituximab use in late antibody-mediated rejection
title_sort rituximab use in late antibody-mediated rejection
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015506/
https://www.ncbi.nlm.nih.gov/pubmed/27795622
http://dx.doi.org/10.4103/0971-4065.179305
work_keys_str_mv AT bansalsb rituximabuseinlateantibodymediatedrejection